EKF Diagnostics Holdings PLC Trading update (9458L)
October 07 2016 - 2:00AM
UK Regulatory
TIDMEKF
RNS Number : 9458L
EKF Diagnostics Holdings PLC
07 October 2016
EKF Diagnostics Holdings plc
("EKF", the "Company")
Trading update
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed
point-of-care business, announces that trading in Q3 of the current
financial year was materially higher than budget and at a run-rate
in excess of market forecasts. As a result the Company is now
confident of achieving revenues and adjusted EBITDA for 2016 which
will exceed the high end of current market forecasts.
In addition, the Company announces that cash generation during
the quarter has been strong and its net debt position has improved
considerably. While the Company plans to continue investing during
Q4 and early 2017 in capital expenditure to increase consumables
capacity in Germany and to replace equipment in the USA, it now
expects to be cash positive within the next 12 months.
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) No 596/2014.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Tel: 029 2071 0570
Chairman
Julian Baines, CEO
Richard Evans, FD & COO
Panmure Gordon (UK) Limited Tel: 020 7886 2500
(NOMAD & Joint Broker)
Freddy Crossley / Peter Steel
(Corporate Finance)
N+1 Singer (Joint Broker) Tel: 020 7496 3000
Alex Price / Alex Laughton-Scott
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLFFILIRLRIIR
(END) Dow Jones Newswires
October 07, 2016 02:00 ET (06:00 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024